Pingkian, Ruro Alistair .
HRN: 22-57-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
OXACILLIN 500MG (VIAL)
02/06/2023
02/12/2023
IVT
170mg
Q6
Pcap D, Submandibular Mass
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes